Science & Technology
Synergy between Artificial Intelligence and DNA-Encoded Library technologies to Identify Polypharmacological Therapeutics for Substance Use Disorders
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43DA062975-01
Award Ceiling
$399K
Award Floor
$399K
Close Date
Apr 30, 2026
46 days leftTotal Funding
$399K
Expected Awards
1
Posted Date
May 15, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R43DA062975-01
Description
SBIR Phase Phase I award: "Synergy between Artificial Intelligence and DNA-Encoded Library technologies to Identify Polypharmacological Therapeutics for Substance Use Disorders" awarded to JiLLiON Therapeutics Inc. in New York, New York. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $399,483. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.